ATE189701T1 - Impfstoffe gegen actinobacillus pleuropneumonie - Google Patents

Impfstoffe gegen actinobacillus pleuropneumonie

Info

Publication number
ATE189701T1
ATE189701T1 AT92921223T AT92921223T ATE189701T1 AT E189701 T1 ATE189701 T1 AT E189701T1 AT 92921223 T AT92921223 T AT 92921223T AT 92921223 T AT92921223 T AT 92921223T AT E189701 T1 ATE189701 T1 AT E189701T1
Authority
AT
Austria
Prior art keywords
pleuropneumoniae
vaccines
vaccines against
against actinobacillus
disclosed
Prior art date
Application number
AT92921223T
Other languages
English (en)
Inventor
Andrew A Potter
Gerald Gerlach
Philip J Willson
Amalia Rossi-Campos
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE189701T1 publication Critical patent/ATE189701T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92921223T 1991-10-22 1992-10-21 Impfstoffe gegen actinobacillus pleuropneumonie ATE189701T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78091291A 1991-10-22 1991-10-22
US07/961,522 US5417971A (en) 1991-10-22 1992-10-15 Vaccines for Actinobacillus pleuropneumoniae
PCT/CA1992/000460 WO1993008283A1 (en) 1991-10-22 1992-10-21 Vaccines for actinobacillus pleuropneumoniae

Publications (1)

Publication Number Publication Date
ATE189701T1 true ATE189701T1 (de) 2000-02-15

Family

ID=27119774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921223T ATE189701T1 (de) 1991-10-22 1992-10-21 Impfstoffe gegen actinobacillus pleuropneumonie

Country Status (9)

Country Link
US (4) US5417971A (de)
EP (1) EP0610260B1 (de)
AT (1) ATE189701T1 (de)
AU (1) AU2751392A (de)
CA (1) CA2121364C (de)
DE (1) DE69230671T2 (de)
DK (1) DK0610260T3 (de)
ES (1) ES2146214T3 (de)
WO (1) WO1993008283A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656477B1 (en) * 1992-07-28 2003-12-02 Board Of Trustees Of Michigan State University 43 Kd protein vaccine and method for the production thereof
ES2270420T3 (es) * 1993-11-08 2007-04-01 Sanofi Pasteur Limited Genes receptores de la transferrina de haemophilus.
US5698394A (en) * 1994-06-01 1997-12-16 Board Of Regents Of The University Of Nebraska Nucleotide sequences and methods for detection of Serpulina hyodysenteriae
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
ES2092960B1 (es) * 1995-03-24 1997-07-01 Hipra Lab Sa Gen de la proteina 1 de union a transferrina (tbp1) de actinobacillus pleuropneumoniae, utilizacion de esta en la preparacion de productos para la vacunacion contra la pleuroneumonia y en reactivos de diagnostico.
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US6440701B1 (en) 1996-03-08 2002-08-27 Aventis Pasteur Limited Transferrin receptor genes of Moraxella
US6617156B1 (en) * 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6391316B1 (en) 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
US7241449B1 (en) 1999-04-12 2007-07-10 Aventis Pasteur Limited Transferrin receptor genes of moraxella
DE19928073B4 (de) * 1999-06-14 2005-12-29 Gerlach, Gerald-F., Prof. Dr. Transkonjugationsplasmid für die Mutagenese von Pasteurellaceae
US7076437B1 (en) 1999-10-29 2006-07-11 Victor Levy Process for consumer-directed diagnostic and health care information
US7985564B2 (en) * 2003-11-21 2011-07-26 Pfenex, Inc. Expression systems with sec-system secretion
EP2468869B1 (de) * 2007-01-31 2015-03-18 Pfenex Inc. Bakterielle Leader-Sequenzen für erhöhte Expression
KR101491795B1 (ko) 2013-06-13 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 1번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
EP3077512B1 (de) 2013-12-02 2022-02-09 Engineered Antigens Inc. Immunogene zusammensetzungen und impfstoffe, abgeleitet von bakteriellen oberflächenrezeptorproteinen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
FR2652266B1 (fr) * 1989-09-26 1994-08-12 Rhone Merieux Vaccin protecteur contre l'hemophilose porcine.
US5641653A (en) * 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin
WO1991012591A1 (en) * 1990-02-14 1991-08-22 Massachusetts Institute Of Technology Fractal-based image compression and interpolation
DE69110082T2 (de) * 1990-04-20 1995-11-09 Akzo Nobel Nv Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.

Also Published As

Publication number Publication date
US5521072A (en) 1996-05-28
DE69230671D1 (de) 2000-03-16
AU2751392A (en) 1993-05-21
DE69230671T2 (de) 2000-08-31
ES2146214T3 (es) 2000-08-01
US5876725A (en) 1999-03-02
CA2121364C (en) 2008-02-19
WO1993008283A1 (en) 1993-04-29
US5801018A (en) 1998-09-01
US5417971A (en) 1995-05-23
EP0610260A1 (de) 1994-08-17
DK0610260T3 (da) 2000-07-24
CA2121364A1 (en) 1993-04-29
EP0610260B1 (de) 2000-02-09

Similar Documents

Publication Publication Date Title
ATE189701T1 (de) Impfstoffe gegen actinobacillus pleuropneumonie
DK0737207T3 (da) Inhibitorer for humant plasmin afledt af Kunitz-domæner
ATE184052T1 (de) Gdf-1 und uog1 proteine
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
NO964862D0 (no) Papillomavirusvaksiner
IL110284A0 (en) Viral vectors and their use in gene therapy
ATE120489T1 (de) Rekombinante coccidiosis-vakzine.
CY1106350T1 (el) Εμβολιο φυματιωσης
IT8321289A0 (it) Composizione farmaceutica contenente almeno in parte endotossina detossificata e suo impiego terapeutico.
NZ229679A (en) Recombinant dna sequence encoding an emeria peptide, the peptide and poultry vaccine against coccidiosis
FI941851A7 (fi) Borrelia Burgdorferi -organismin (Bb) virulenssiin liittyvät proteiini t
CA2148369A1 (en) Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
NO950420D0 (no) Interferon endelse derav
DE3650692D1 (de) Rekombinantes Ricin-Toxin
ATE320266T1 (de) Induktion von antigen-spezifischen t-zellen durch interferon
DK703588D0 (da) Pai-1-blokerende peptider, deres fremstilling og anvendelse
DK381787D0 (da) Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
FI920030A7 (fi) IBDV-proteiiniin liittyviä spesifisiä DNA-sekvenssejä sekä vektoreita, isäntiä ja rokotteita
IT9021846A1 (it) Involucro pretettivo, particolarmente studiato per l'impiego in ambito ospedaliero.
IT8901231A0 (it) Bottiglia con canna trasversale nel corpo.
ITTO910178U1 (it) Cucchiaio, eliminabile dopo l'uso, con condimento.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties